ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1354	National Cancer Institute	Html	null	Melanoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of melanoma.			CLICK HERE
1417	National Cancer Institute	Html	en	Stomach (Gastric) Cancer Prevention (PDQ®)–Health Professional Version	Risk factors for stomach (gastric) cancer include certain health conditions (e.g., atrophic gastritis, pernicious anemia, H. pylori infection), genetic factors (e.g., Li-Fraumeni syndrome), or environmental factors (e.g., diet, smoking). Review the evidence on these and other risk factors and interventions to prevent stomach cancer in this expert-reviewed summary.	randomized placebo-controlled trial 0.595383 gastric adenomatous polyps 0.679902 experimental animal models 0.575229 infected family members 0.578256 antioxidant dietary supplements 0.574787 H. pylori 0.663672 annual incidence rates 0.588818 secondary prevention measures 0.572741 age-adjusted incidence rate 0.59463 statistically significant reduction 0.578799 combined antioxidant groups 0.572868 H. pylori infection 0.650947 high H. pylori 0.585004 family members 0.581961 gastric cancer mortality 0.686327 endoscopic resection techniques 0.578064 placebo group 0.585452 chemoprevention trial 0.590009 H. pylori-infected family 0.583244 Li Fraumeni syndrome 0.58425 intestinal metaplasia 0.628781 advanced premalignant lesions 0.570945 protective effects 0.575049 low selenium content 0.586292	statistically significant effect 0.623477 Beta Carotene trial 0.587524 United States 0.702911 gastric cancer incidence. 0.664051 precancerous gastric lesions. 0.647932 5-year survival rate 0.635247 gastric cancer cases 0.674324 gastric cancers 0.625749 gastrointestinal cancers 0.575893 H. pylori-infected people 0.581367 overall 5-year survival 0.57409 beta carotene 0.671292 small randomized trial 0.598139 gastric cancer 0.97116 gastric adenocarcinoma. 0.625249 eradication therapy 0.572355 Chinese medical journal 0.572216 vitamin supplementation 0.570623 statistically significant regression 0.573687 chronic atrophic gastritis 0.586209 gastric cancer. 0.610162 close family members. 0.576811 family history 0.58364 steady incidence rates 0.587586	CLICK HERE
1430	National Cancer Institute	Html	en	Stomach (Gastric) Cancer Prevention (PDQ®)–Patient Version	Smoking and H. pylori infection are important risk factors for stomach (gastric) cancer. Learn about all of the risk factors for stomach cancer and how to prevent stomach cancer in this expert-reviewed summary.	PDQ Screening 0.364501 cancer risk factors 0.420087 cancer treatment 0.365273 Cancer prevention 0.532051 cancer prevention trials 0.402318 healthy diet 0.359621 cancer protective factor 0.402244 United States 0.45543 prevention clinical trials 0.399973 protective factors 0.416286 antibiotics lowers 0.358249 following PDQ summaries 0.402867 Cancer Information Service 0.393528 PDQ cancer information 0.513502 number 0.358741 Clinical Trials section 0.366407 common cancer 0.369836 Prevention Editorial Board 0.402679 treatment clinical trials 0.365364 dietary supplements 0.383267 H. pylori bacteria 0.36065 National Cancer Institute 0.462669 clinical trials 0.512934	PDQ documents 0.365522 beta carotene 0.388269 health care 0.357632 cancer information summary 0.455266 cancer doctors 0.360396 new treatment 0.364974 breast cancer prevention 0.387351 cancer patients 0.36264 Cancer Care page 0.385527 PDQ database 0.368612 latest published information 0.364412 cancer risk factor 0.42115 NCI’s PDQ 0.372914 PDQ summary 0.382762 NCI PDQ cancer 0.429445 cancer clinical trials 0.401358 stomach cancer 0.900678 risk factors 0.486241 cancer information summaries 0.399032 comprehensive cancer information 0.399493 stomach cancer prevention 0.492255 risk 0.486594	CLICK HERE
1478	National Cancer Institute	Html	en	Skin Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of skin cancer.	treatment 0.409923 metastatic basal cell 0.400394 subsequent basal cell 0.391984 Skin Cancer Prevention 0.365074 Arch Dermatol 0.471327 photodynamic therapy 0.399886 sun-exposed skin 0.375699 skin cancers 0.433811 primary skin cancers 0.370681 uncomplicated basal cell 0.398522 basal-cell carcinoma 0.373761 PUBMED Abstract 0.376972 Mohs micrographic surgery 0.406259 Invest Dermatol 0.363857 prior skin cancer 0.363746 multiple basal cell 0.397256 nonmelanoma skin cancers 0.400983 recurrence rates 0.396208 Dermatol Surg Oncol 0.421496 periocular basal cell 0.39808 BCC 0.370104 Abstract 0.389392 main skin cancer 0.382703 basal cell nevus 0.404293	squamous cell carcinomas 0.385705 eyelid addresses carcinomas 0.365517 non-eyelid skin cancers 0.367643 surgical excision 0.369879 Br J Dermatol 0.407426 cosmetic results 0.379562 superficial basal cell 0.487048 skin cancer awareness 0.383438 basal cell carcinomas 0.527823 nodular skin BCCs 0.369486 nodular basal cell 0.432753 nonmelanoma skin cancers. 0.373768 nevoid Basal cell 0.396437 primary superficial basal 0.391239 radiation therapy 0.475907 nonmelanoma skin cancer 0.483068 basal cell carcinoma 0.980145 regional lymph nodes 0.369237 radiation therapy treatment 0.376744 longstanding skin ulcers 0.361677 et al. 0.442813 Acad Dermatol 0.422124 squamous cell carcinoma 0.41423	CLICK HERE
1596	National Cancer Institute	Html	en	Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of extragonadal germ cell tumors.	malignant extragonadal germ 0.298746 malignant tumor cells 0.298137 cancer treatment 0.292355 Cell Tumors Treatment 0.262583 cancer spreads 0.256757 body 0.292404 germ cell tumor 0.536364 following PDQ summaries 0.254729 PDQ cancer information 0.314684 clinical trial search 0.300526 clinical trials 0.586387 blood levels 0.251953 cancer information summary 0.288819 Benign extragonadal germ 0.279683 clinical trial 0.399211 good prognosis group 0.254652 stem cell transplant 0.261231 tumor markers 0.32423 patients 0.268211 treatment clinical trial 0.259833 PDQ Adult Treatment 0.25471 NCI PDQ cancer 0.263605 extragonadal germ cell 0.973537 radiation therapy 0.307388 Treatment Editorial Board 0.266625	poor prognosis group 0.253054 seminoma extragonadal germ 0.342778 General information 0.25607 Serum tumor marker 0.272202 treatment 0.407159 new cancer treatments 0.252812 NCI-supported cancer 0.263007 cancer cells 0.297225 Cancer Information Service 0.252834 treatment clinical trials 0.280785 National Cancer Institute 0.29056 tumor cells 0.30292 new treatment 0.320955 primary tumor 0.264969 prognosis group 0.287143 metastatic tumor 0.274305 blood 0.260611 nonseminoma extragonadal germ 0.343285 germ cell tumors 0.795411 cancer clinical trials 0.308911 cancer information summaries 0.252228 comprehensive cancer information 0.25212 cancer 0.522779 standard treatment 0.259689	CLICK HERE
1951	National Cancer Institute	Html	es	Tratamiento de los síndromes mielodisplásicos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los síndromes mielodisplásicos.	siguientes procedimientos 0.408317 displasia multilinaje 0.404818 células madre 0.698581 leucemia aguda 0.40611 síndromes mielodisplásicos 0.99284 hueso compacto 0.416921 neoplasias mieloides 0.402645 plaquetas maduras 0.410918 célula madre mieloide 0.437557 National Cancer Institute 0.402744 siguientes riesgos 0.401921 vitamina b12 0.403995	Instituto Nacional 0.404912 PDQ Tratamiento 0.439829 célula madre linfoide 0.43173 vidrio piezas 0.403146 neoplasias mielodisplásicas 0.404775 displasia unilinaje 0.404747 Physician Data Query 0.410747 cáncer.ampliar trasplante 0.403337 leucemia mieloide aguda 0.59748 célula madre 0.50311 células sanguíneas maduras 0.465531 siguientes pruebas 0.40454	CLICK HERE
1989	National Cancer Institute	Html	es	Cuidados médicos de apoyo en niños (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de la peculiaridad de los asuntos que surgen durante y después del tratamiento en los niños con cáncer, y como sobrevivientes adultos de cáncer.	etapa final 0.974283 posibles efectos tardíos 0.445113 células madre 0.448459 adultos jóvenes 0.631616 personas jóvenes 0.478657 posibles tratamientos 0.424654 siguientes aspectos 0.421705 cáncer causa estrés 0.501532 apoyo social escaso 0.437899 siguientes tipos 0.415041 largo plazo 0.418906 efectos tardíos 0.530812 familia reaccionarán 0.418853 National Cancer Institute 0.415958 siguientes riesgos 0.411551	siguientes maneras 0.446878 Instituto Nacional 0.427962 síntomasEl trastorno 0.423462 Cuidado paliativo 0.412419 distintos miembros 0.413316 tratamiento ayuda 0.457106 suicidioUn número 0.419685 siguientes efectos 0.419968 posibles efectos 0.465562 Physician Data Query 0.458553 sistema nervioso central 0.433857 mayores probabilidades 0.421125 Estados Unidos 0.416849 mejores tratamientos 0.417691	CLICK HERE
2025	National Cancer Institute	Html	es	Exámenes de detección del cáncer colorrectal (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre las pruebas que se usan para detectar el cáncer colorrectal.	PDQ Exámenes 0.849253 Physician Data Query 0.949845 sigmoidoscopia causa 0.801378 tubo recolector 0.784476 Estados Unidos 0.979222 riesgos.Los exámenes 0.85829 cuerpo).ampliar anatomía 0.797555 prevención revisa 0.744583 radiografías llamada 0.774966	PDQ Prevención 0.956837 pequeño aumento 0.790999 siguientes exámenes 0.980519 información ayuda 0.751125 National Cancer Institute 0.760892 siguientes riesgos 0.742979 siguientes sumarios 0.885224 Instituto Nacional 0.814155	CLICK HERE
15774	National Cancer Institute	Html	en	Cancer Clinical Trials API	Access NCI-supported cancer clinical trials information through an application programming interface (API).	IND/IDE information 0.322332 search tools 0.31747 initial working piece 0.395837 clinical trial information 0.444384 application programming interface 0.438002 developers 0.217415 CTRP information 0.321432 questions 0.217374 Clinical Trials Reporting 0.43587 NCI-supported cancer 0.32979 biomarker data 0.321606 feedback 0.238876 clinical trial search 0.427355 database 0.218238 academia 0.222589 NCI-specific Data Table 0.401719 individual communities 0.317208 contact 0.217352 large amounts 0.326709 clinical trials 0.959644 family members 0.316516 summary 0.217584	community—advocacy groups 0.318407 ct-api-support@nih.gov. 0.306404 Clinical Trials API 0.843331 beta version 0.313025 https://clinicaltrialsapi.cancer.gov 0.217378 meaningful ways 0.325497 regulatory information 0.322729 common language 0.320268 patients 0.239672 Documentation 0.217429 digital platforms 0.317392 public web 0.304451 help 0.217404 better search results 0.40957 cancer clinical trials 0.743102 IRB approval details 0.415735 accrual information 0.335388 oncologists 0.229097 integrations 0.227372 providers 0.219039 Trials Beta API 0.505116	CLICK HERE
16829	National Cancer Institute	Html	en	Cancer Driver Discovery Program	null	large number 0.638311 tumor biology 0.66038 rare driver events 0.719635 comprehensive genomic characterization 0.740363 genomic analyses 0.633135 patient responses 0.721865 tumor tissues 0.638276 additional driver mutations 0.771411 lung cancer 0.952268 statistical models 0.628862 statistical power 0.629897 cancer genomics 0.65394 recurrent mutations 0.655852 patients 0.702611 Genomic Data Commons 0.762952 clinical trial N0147 0.722969 Lung Cancer project 0.792668 molecular causes 0.642033 oncogenic process 0.640394 public health impact 0.739202 epidermal growth factor 0.708102 tumor types 0.658904 Cancer Driver Discovery 0.8155 DNA sequencing 0.651327 Cancer Research UK 0.776689	RNA sequence 0.636519 associated follow-up information 0.721592 ovarian cancers 0.639935 better treatment options 0.776737 clinical outcomes 0.638824 Foundation Lung Cancer 0.793933 intratumoral heterogeneity 0.742723 deeper characterization 0.652385 TRACERx collaborators 0.637079 NCI-funded clinical trial 0.73112 Genome Characterization Pipeline 0.748856 driver mutations 0.919706 St. James 0.824605 Tracking Cancer Evolution 0.775958 CCG 0.851349 colon cancer 0.744767 lung adenocarcinoma 0.669686 TRACERx study 0.634122 total RNA sequencing 0.961331 Cancer Genome Atlas 0.832019 chemotherapy regimen 0.639583 particular lung cancer 0.807795 Central Cancer Treatment 0.762707 genome sequencing 0.685209	CLICK HERE